TRIGGIANI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 7.889
AS - Asia 2.222
EU - Europa 2.012
SA - Sud America 410
AF - Africa 16
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.568
Nazione #
US - Stati Uniti d'America 7.864
SG - Singapore 745
CN - Cina 626
UA - Ucraina 497
IT - Italia 470
BR - Brasile 344
RU - Federazione Russa 337
VN - Vietnam 328
TR - Turchia 232
DE - Germania 222
IE - Irlanda 209
KR - Corea 138
FI - Finlandia 91
SE - Svezia 74
HK - Hong Kong 70
AR - Argentina 44
AT - Austria 29
GB - Regno Unito 27
IN - India 24
NL - Olanda 11
CZ - Repubblica Ceca 10
IQ - Iraq 10
NZ - Nuova Zelanda 9
CA - Canada 8
EC - Ecuador 7
FR - Francia 7
PK - Pakistan 7
AU - Australia 6
BD - Bangladesh 6
ES - Italia 5
MX - Messico 5
UZ - Uzbekistan 5
VE - Venezuela 5
ZA - Sudafrica 5
CH - Svizzera 4
EU - Europa 4
JO - Giordania 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
BE - Belgio 3
CR - Costa Rica 3
IL - Israele 3
KE - Kenya 3
MK - Macedonia 3
PE - Perù 3
PL - Polonia 3
PY - Paraguay 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BZ - Belize 2
CO - Colombia 2
DO - Repubblica Dominicana 2
JP - Giappone 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
AL - Albania 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MM - Myanmar 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 12.568
Città #
Ann Arbor 2.093
Woodbridge 1.132
Chandler 699
Jacksonville 661
Princeton 627
Houston 536
Wilmington 392
Dong Ket 326
Ashburn 271
Singapore 252
Izmir 222
Dublin 206
Andover 147
Nanjing 133
Boardman 113
Beijing 105
Moscow 104
Pellezzano 103
Hong Kong 70
Naples 55
Salerno 54
Washington 54
Düsseldorf 50
Shenyang 49
Changsha 45
Fairfield 45
Nuremberg 44
Hebei 42
Norwalk 39
Jiaxing 38
Nanchang 37
Redwood City 37
Buenos Aires 32
Dearborn 27
Dallas 25
Tianjin 25
São Paulo 23
Mestre 18
Los Angeles 17
Rome 17
Milan 16
Pune 15
Seattle 15
Council Bluffs 13
Lappeenranta 13
Vienna 13
Cambridge 11
Belo Horizonte 10
Latina 10
Rio de Janeiro 10
Falls Church 9
Jinan 9
Brno 8
Munich 8
Raleigh 8
San Diego 8
Shanghai 8
Chicago 7
Curitiba 7
Guangzhou 7
Springfield 7
Amsterdam 6
Salvador 6
Southampton 6
Auckland 5
Florence 5
Quito 5
Santa Clara 5
Volta Redonda 5
Amman 4
Assago 4
Baghdad 4
Fuzhou 4
Guarulhos 4
Hefei 4
Istanbul 4
Jinhua 4
London 4
Piacenza 4
San Jose 4
Tashkent 4
The Dalles 4
Asunción 3
Belém 3
Blumenau 3
Brasília 3
Columbus 3
Contagem 3
Frechen 3
Giugliano in Campania 3
Gunzenhausen 3
Hangzhou 3
Indiana 3
Kunming 3
Maceió 3
Madrid 3
Manassas 3
Nairobi 3
New York 3
Orange 3
Totale 9.326
Nome #
La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee 176
A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema 143
Antigen-induced generation of lyso-phospholipids in human airways. 134
Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases 128
Current concepts on diagnosis and treatment of mastocytosis. 118
Allergia alimentare e probiotici: nuovi aspetti sulle interazioni tra il sistema immunitario ed i batteri commensali intestinali 115
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. 114
Editorial overview: Immunomodulation: Modulation of the immune system: Per aspera ad astra 112
Activation of human inflammatory cells by secreted phospholipases A2 112
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell. 109
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. 108
L'acido ialuronico nella regolazione delle risposte infiammatorie ed immunologiche 108
Antileucotrieni nell'asma bronchiale: bilancio e prospettive 106
Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications 106
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. 105
Anaphylaxis and cardiovascular diseases 104
Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor 104
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 104
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 103
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis 101
Are mast cells MASTers in HIV-1 infection? 98
Molecular diagnosis and the Italian Board for ISAC. 97
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 95
Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 95
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal 94
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 93
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 91
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future 91
Expression and function of angiopoietins and their tie receptors in human basophils and mast cells 90
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 90
Sensitization to Common and Uncommon Pets or Other Furry Animals: Which May Be Common Mechanisms? 89
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: The Italian experience 88
A unique case of angioedema with anti-C1 inhibitor antibodies and normal C1 inhibitor levels 88
Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema 88
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. 87
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. 86
Research needs in allergy: an EAACI position paper, in collaboration with EFA 86
What we should learn from the London Olympics 86
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 86
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis 86
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 85
Molecular and cellular biology of mast cells and basophils. 84
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 84
Control of arachidonate levels within inflammatory cells. 84
Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils 84
Pharmacological modulation of human mast cells and basophils 84
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 83
Role of human mast cells and basophils in bronchial asthma. 83
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. 83
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 83
A review of hereditary angioedema and recombinant human C1-inhibitor treatment 83
Management of chronic spontaneous urticaria: practical parameters 83
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 83
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases 83
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations 82
Stress and Psychological Factors in the Variable Clinical Phenotype of Hereditary Angioedema in Children: A Pilot Study 81
Role of human FcεRI+ cells in HIV-1 infection 81
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes 80
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 80
Metabolism of platelet-activating factor in the guinea-pig heart. 80
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. 80
Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. 80
Phenotypical and functional heterogeneity of human lung macrophages 80
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 80
Mastocytosis presenting as cardiac emergency 80
Oxidative stress markers are increased in patients with mastocytosis 79
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. 79
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives 79
A Survey of Clinical Features of Allergic Rhinitis in Adults 78
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 78
Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. 78
Metabolism of lipid mediators in human basophils and mast cells. 78
Perioperative anaphylactic risk score for risk-oriented premedication. 78
HIV-1 envelope gp41 peptides promote migration of human FcεRI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors 78
Potential benefit of omalizumab in respiratory diseases 77
Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. 76
Studi tossicologici sugli effetti dell'idrochinone e del benzochinone sui basofili umani 76
Biomarkers for evaluation of mast cell and basophil activation 76
Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. 75
Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid. 75
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. 75
Mast cells as effector cells of innate immunity and regulators of adaptive immunity 75
Evaluation of vaccination safety in children with mastocytosis 75
Chemical mediators and the human heart. 74
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 74
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. 74
Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor. 73
Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide 72
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology 71
Human mast cells and basophils in HIV-1 infection 71
Metabolism of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 70
Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. 70
Basophil count in neonates is not suitable for atopy predictivity. 70
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. 70
Mast cells, basophils and their mediators 70
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 70
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 70
Immunopharmacological modulation of mast cells 70
Effect of activation of the H1 receptor on coronary hemodynamics in man. 68
Secretory phospholipase A2: a putative mediator of airway inflammation 68
Totale 8.757
Categoria #
all - tutte 49.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020222 0 0 0 0 0 0 0 0 0 0 206 16
2020/20211.133 21 82 95 12 151 46 150 22 91 11 99 353
2021/20221.047 9 3 4 18 10 19 9 44 166 139 137 489
2022/20231.740 184 104 59 200 244 388 12 165 260 6 93 25
2023/20241.002 82 110 122 49 97 174 23 44 11 40 47 203
2024/20251.902 79 34 33 96 109 283 353 246 465 199 5 0
Totale 12.872